MCKENZIE BARTLETT: Open Payments
NPI 1134876535 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,901 in 148 payments from 25 companies in 2025. Trend: 2023 $4,195 · 2024 $3,489 · 2025 $2,901
Food & beverage: $2,901
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $582 |
| ABBVIE INC. | 21 | $408 |
| GENZYME CORPORATION | 14 | $333 |
| Galderma Laboratories, L.P. | 16 | $265 |
| UCB, Inc. | 15 | $246 |
| Arcutis Biotherapeutics, Inc. | 13 | $201 |
| Incyte Corporation | 6 | $129 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $102 |
| Lilly USA, LLC | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
Products named: DUPIXENT, SKYRIZI, NEMLUVIO, Bimzelx, Zoryve, COSENTYX, Rhapsido, OPZELURA.
Industry payments across TX — which companies pay providers there.
